Suppr超能文献

肢端黑色素瘤发病率和生存趋势 1990-2020 年:一项全国范围、基于人群的研究。

Acral Melanoma Incidence and Survival Trends in 1990-2020: A Nationwide, Population-based Study.

机构信息

Department of Clinical Sciences Lund, Lund University Skin Cancer Research Group, Lund University, Lund, Sweden, Department of Dermatology and Venereology, Skåne University Hospital, Lund, Sweden.

Clinical and Experimental Medicine, Linköping University, Linköping, Sweden Regional Cancer Centre Southeast Sweden, Linköping, Sweden.

出版信息

Acta Derm Venereol. 2024 Aug 14;104:adv40242. doi: 10.2340/actadv.v104.40242.

Abstract

Acral melanoma is a clinical subtype of melanoma with high mortality, on which research is limited in scope. This study aimed to assess incidence trends and melanoma-specific survival rates for acral melanoma in the Swedish population from 1990 to 2020.This cross-sectional study included patients with an acral melanoma diagnosis from 1990 to 2020 from the nationwide, population-based Swedish Melanoma Registry. Analyses on acral melanoma melanoma-specific survival rates were adjusted for age, sex, histopathological subtype, and tumour thickness. Clinicopathological features and melanoma-specific survival rates were compared between diagnostic periods: 1990-1999, 2000-2009, and 2010-2020, respectively. Changes in standardized incidence rates in 1996-2020 were evaluated separately for males and females. In total, 1,000 acral melanomas in 999 patients were included in the study. No significant yearly change in standardized incidence rates for either males or females was observed, even though the absolute number of cases increased. Factors such as male sex, age ≥ 70 years, and Breslow thickness > 1.0 were independently linked to lower melanoma-specific survival. The 5-year melanoma-specific survival across the studied period ranged from 75.8% to 77.9% for females, and from 62.4% to 71.7% for males.

摘要

肢端黑色素瘤是一种具有高死亡率的黑色素瘤临床亚型,其研究范围有限。本研究旨在评估 1990 年至 2020 年瑞典人群中肢端黑色素瘤的发病率趋势和黑色素瘤特异性生存率。

这项横断面研究纳入了 1990 年至 2020 年期间来自全国性基于人群的瑞典黑色素瘤登记处的肢端黑色素瘤患者。对肢端黑色素瘤的黑色素瘤特异性生存率进行分析时,调整了年龄、性别、组织病理学亚型和肿瘤厚度因素。分别对诊断期(1990-1999 年、2000-2009 年和 2010-2020 年)进行肢端黑色素瘤的临床病理特征和黑色素瘤特异性生存率的比较。

在 1996 年至 2020 年期间,分别评估了男性和女性的标准化发病率变化。研究共纳入了 999 例患者中的 1000 例肢端黑色素瘤。尽管病例数量有所增加,但男性和女性的标准化发病率均未观察到明显的逐年变化。男性、年龄≥70 岁和 Breslow 厚度>1.0 等因素与黑色素瘤特异性生存率降低独立相关。研究期间女性的 5 年黑色素瘤特异性生存率为 75.8%至 77.9%,男性为 62.4%至 71.7%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56f7/11334350/aca866377be2/ActaDV-104-40242-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验